最新文章：伊维菌素和芬苯达唑治疗案例——一位42岁的加拿大女性，患有四期乳腺癌并

最新文章：伊维菌素和芬苯达唑治疗案例——一位42岁的加拿大女性，患有四期乳腺癌并已转移至骨骼，在接受治疗6个月后汇报情况警告：本故事中不涉及化疗！（化疗爱好者们现在最好找个安全的地方待着，因为这个故事可能会触动你们的神经，让你们忍不住尖叫或哭泣。）故事一名42岁的加拿大女性，患有四期乳腺癌，癌细胞已转移至骨骼。2025年4月初，她开始服用：伊维菌素 1mg/kg/天芬苯达唑 1776毫克/天结果：CA125：86至56至21骨转移的愈合减少胸腔积液量。主流肿瘤治疗无法给这类患者带来任何希望。这就是为什么对再利用药物的研究如此重要，也是为什么我很高兴在佛罗里达州引领这一潮流。像伊维菌素、甲苯咪唑和芬咪唑这样的老药新用代表着未来，其他任何药物都无法与之媲美。NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 42 year old Canadian woman with Stage 4 Breast Cancer metastatic to bones reports after 6 monthsWarning: NO CHEMO in this story!(Chemotherapy lovers may want to go find a Safe Space right now, as this story will trigger you and you may need to scream or cry)STORY42 year old Canadian woman with Stage 4 Breast Cancer metastatic to bonesIn early April 2025 she started taking:Ivermectin 1mg/kg/dayFenbendazole 1776mg/dayResults:CA125: 86 to 56 to 21Healing of bone metastasesDecreasing pleural effusion volume.Mainstream Oncology doesn't give patients like this any hope.That's why research into repurposed drugs is so crucial and why I'm so happy that is leading the way in Florida.Repurposed drugs like Ivermectin, Mebendazole and Fenbendazole are the future, nothing else comes remotely close.